Tulane Spin-Out Company to Develop New Treatment for Pelvic Organ Prolapse
July 22, 2021
July 22, 2021
NEW ORLEANS, Louisiana, July 22 (TNSRes) -- Tulane University issued the following news release:
The Eunice Kennedy Shriver National Institute of Child Health & Human Development has awarded a $256,000 grant to BioAesthetics Corp., a Tulane University spin-out company, to develop a new graft for treating pelvic organ prolapse (POP).
BioAesthetics, whose CEO and COO are both Tulane graduates, is collaborating with Tulane researcher Kristin Miller, an associate profes . . .
The Eunice Kennedy Shriver National Institute of Child Health & Human Development has awarded a $256,000 grant to BioAesthetics Corp., a Tulane University spin-out company, to develop a new graft for treating pelvic organ prolapse (POP).
BioAesthetics, whose CEO and COO are both Tulane graduates, is collaborating with Tulane researcher Kristin Miller, an associate profes . . .